Fairmount Funds Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Fairmount Funds Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$144.95 - $152.29 $8.62 Million - $9.06 Million	-59,463 Reduced 22.51%	204,743 $31 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $2.07 Million - $3.63 Million	24,892 Added 10.4%	264,206 $38.5 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $20.2 Million - $26.2 Million	183,667 Added 330.06%	239,314 $28.4 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $5.55 Million - $8.26 Million	55,647 New	55,647 $7.67 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.